Intention

Playground Ventures Announces Completion of Ludare JV, the Proposed Acquisition of Countervail Games Inc. and A Financing

Thursday, June 10, 2021 - 2:07pm

MotionPix is a Vancouver based company that has the exclusive rights to a mobile game project licensed with a major movie franchise.

Key Points: 
  • MotionPix is a Vancouver based company that has the exclusive rights to a mobile game project licensed with a major movie franchise.
  • In 2021, he was also named as one of the Top 24 people of Asian Descent to Watch by the Vancouver Economic Commission.
  • Playground Ventures is also pleased to announce that it has entered a non-binding letter of intent (the "LOI") to acquire (the "Countervail Acquisition") all of the issuance and outstanding common shares in the capital of Countervail Games Ltd ("Countervail").
  • Accordingly, pursuant to MI 61-101, the Countervail Acquisition is subject to the minority shareholder approval and the formal valuation requirements of MI 61-101.

America's Mask Challenge Provides Masks to Schools in 50 States

Thursday, May 6, 2021 - 5:29pm

"United Way believes that protecting vulnerable groups in society, starting with our children and their educators, is not just a moral imperative, it is also practical.

Key Points: 
  • "United Way believes that protecting vulnerable groups in society, starting with our children and their educators, is not just a moral imperative, it is also practical.
  • We will strive to reverse the disruptive impact that school closures have had on our children everywhere.
  • "\nFor more information on America\'s Mask Challenge, please visit: https://www.unitedway.org/pages/maskchallenge\nUnited Way fights for the health, education and financial stability of every person in every community.
  • With global reach and local impact, we\'re making life better for48millionpeopleannually.UnitedWay is the world\'s largest privately funded nonprofit,workingin95% of U.S.communitiesand40countriesand territories.

Predictmedix Inc. Announces LOI to Acquire Symp2pass Inc.

Tuesday, March 23, 2021 - 2:32pm

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce it has entered into a letter of intent (the "LOI"), to acquire Symp2Pass Inc. ("Symp2pass") (the "Acquisition").

Key Points: 
  • TORONTO, March 23, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce it has entered into a letter of intent (the "LOI"), to acquire Symp2Pass Inc. ("Symp2pass") (the "Acquisition").
  • The LOI was executed on February 24, 2021 and currently Predictmedix and Symp2pass are working on the definitive agreement.
  • Much like Predictmedixs Safe Entry Station units, Symp2Pass affords hardware product installation that is coupled with scalable, AI powered software technologies.
  • There is one word that encapsulates our decision to acquire the Symp2Pass product suite from SmartCone synergy.

Powecom to Increase Production Supply of Its Genuine Powecom FDA Authorized KN95 Face Masks Exclusively for Bona Fide Masks™ (www.bonafidemasks.com)

Tuesday, February 9, 2021 - 6:53pm

Co., Inc. family of companies, today confirmed that Guangzhou Powecom Labor Insurance Supplies Co., Ltd. (Powecom) will make more of its FDA authorized KN95 expressly for Bona Fide Masks, Powecom's premier authorized U.S. distributor.

Key Points: 
  • Co., Inc. family of companies, today confirmed that Guangzhou Powecom Labor Insurance Supplies Co., Ltd. (Powecom) will make more of its FDA authorized KN95 expressly for Bona Fide Masks, Powecom's premier authorized U.S. distributor.
  • Jing Yip, Powecom's Marketing and Export Officer, states, "'We are increasing KN95 production for our most important U.S. partner, Bona Fide Masks.
  • Even during the Chinese New Year, we will produce and ship masks expressly for Bona Fide Masks.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/powecom-to-increase-production-s...
    SOURCE Ball Chain Manufacturing Co., Inc.; Powecom; Bona Fide Masks

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Friday, January 29, 2021 - 10:00pm

The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules.

Key Points: 
  • The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules.
  • The options have an exercise price of $32.12 per share, which is equal to the closing price of Esperion's common stock on January 28, 2021.
  • Our team of lipid experts works to lower bad cholesterol by discovering, developing and commercializing innovative medicines and combinations with established medicines.
  • We work hard to make our medicines easy to take, easy to get and easy to have.

RISE Life Science Corp. Announces Proposed Transaction with Britannia Life Sciences

Friday, January 22, 2021 - 3:50pm

Toronto, Ontario--(Newsfile Corp. - January 22, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has entered into an agreement with Britannia Bud Canada Holdings Inc., dba Britannia Life Sciences ("Britannia"), dated January 21, 2021 to amend and confirm a letter of intent previously agreed to by the parties (the "Agreement"), pursuant to which RISE and Britannia have agreed to complete a business combination transaction (the "Proposed Transaction").

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - January 22, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has entered into an agreement with Britannia Bud Canada Holdings Inc., dba Britannia Life Sciences ("Britannia"), dated January 21, 2021 to amend and confirm a letter of intent previously agreed to by the parties (the "Agreement"), pursuant to which RISE and Britannia have agreed to complete a business combination transaction (the "Proposed Transaction").
  • The Proposed Transaction will not constitute a non-arm's length transaction or related party transaction under the relevant securities legislation or CSE policies.
  • RISE and Britannia have mutually agreed to an appropriate break fee in the event either party elects to pursue an alternative transaction.
  • In connection with the Proposed Transaction, Britannia is currently closing a private round of financing of up to $5 million USD.

BlockchainK2 Announces Letter of Intent to Acquire Equiti Games, LLC

Monday, January 4, 2021 - 1:00pm

Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - BlockchainK2 Corp. (TSXV: BITK) (OTCQB: BIDCF) (STU: KRL2) ("BlockchainK2" or the "Company")is pleased to announce that it has signed a non-binding letter of intent (the "LOI") regarding the acquisition of 100% of the business of Equiti Games, LLC ("EG").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - BlockchainK2 Corp. (TSXV: BITK) (OTCQB: BIDCF) (STU: KRL2) ("BlockchainK2" or the "Company")is pleased to announce that it has signed a non-binding letter of intent (the "LOI") regarding the acquisition of 100% of the business of Equiti Games, LLC ("EG").
  • The parties have agreed to an exclusivity period until February 28, 2021 with a view to settling the definitive agreement.
  • However, there can be no assurance that the transaction will be completed as proposed or at all.
  • The Company does not intend, and does not assume any obligation, to update these forward-looking statements except as otherwise required by applicable law.

The Counseling Center Of New England To Join Lifestance Health Brand, Affirm Commitment To Clients

Wednesday, December 16, 2020 - 3:43pm

Since 2017, The Counseling Center of New England has been part of the LifeStance Health family.

Key Points: 
  • Since 2017, The Counseling Center of New England has been part of the LifeStance Health family.
  • Now, the practice will unify with other LifeStance Health clinics across the country under the LifeStance Health name.
  • The Counseling Center of New England will officially change its name to LifeStance Health on March 1, 2021, though the transition will begin in early January.
  • As the need for access to high-quality behavioral health services has grown over the years, The Counseling Center of New England and LifeStance Health have risen to meet those needs.

Leo Acquisitions Enters into Binding Letter of Intent for Qualifying Transaction with PsyBio Therapeutics

Monday, October 5, 2020 - 9:21pm

TORONTO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (Leo or the Company) and PsyBio Therapeutics, Inc. (PsyBio) are pleased to announce that they have entered into a binding letter of intent dated October 5, 2020, pursuant to which Leo and PsyBio intend to complete a business combination or other similarly structured transaction which will constitute a reverse take-over of Leo (the Transaction).

Key Points: 
  • TORONTO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (Leo or the Company) and PsyBio Therapeutics, Inc. (PsyBio) are pleased to announce that they have entered into a binding letter of intent dated October 5, 2020, pursuant to which Leo and PsyBio intend to complete a business combination or other similarly structured transaction which will constitute a reverse take-over of Leo (the Transaction).
  • It is intended that the Transaction will be an arms length Qualifying Transaction for Leo, as such term is defined in Policy 2.4 of the Corporate Finance Manual of the TSX Venture Exchange (the TSXV).
  • PsyBio is a US-basedbiotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders.
  • There are no relationships between any non-arms length party of Leo and PsyBio or its assets and the Transaction will be an arms length transaction.

Integrated Ventures Reports 63% Increase In Year To Year Revenues

Thursday, September 24, 2020 - 2:43pm

Year to year revenues had increased by $175,027 or 63%, from $279,143, for the year ended June 30, 2019.

Key Points: 
  • Year to year revenues had increased by $175,027 or 63%, from $279,143, for the year ended June 30, 2019.
  • After performing standard due diligence, Integrated Ventures has decided against pursuing M&A transaction with Petawatt Properties.
  • In September, Integrated Ventures had executed Letter of Intent ("LOI") to acquire assets of private company with unaudited 2019 revenues of $1.75 million.
  • About Integrated Ventures, Inc: The Company operates as Technology Holdings Company with focus on operating assets in technology and cryptocurrency sectors.